Abridge
Abridge is an AI tool built for one job: listening to a doctor and patient talk, then turning that conversation into a finished clinical note before the visit even ends. This review looks at the product as most health systems actually buy it — through an enterprise contract, since there's no plan an individual clinician can just sign up for on their own.
How Abridge scores
Abridge has built the strongest evidence base in its category, and that's not a small thing in healthcare, where a wrong or sloppy note can affect patient care and get you sued. Doctors using it report less burnout, more attention on the actual patient in front of them, and notes finished before the next appointment starts instead of piling up after hours. What the independent research doesn't fully back up is the idea that it saves huge amounts of time — the most careful study of Abridge specifically found the note-writing time drop was under a minute per note, a real number, just a much smaller one than the burnout headlines suggest. We'd point any large health system already running Epic toward Abridge first, given how deep that integration goes and how much research backs the clinical side. We'd tell a smaller practice or an independent doctor to keep looking, since there's no way to just sign up and try it without going through a full enterprise sales process.
Pros
- The note doesn't just summarize the conversation — every section links back to the exact spot in the recording that produced it, so a doctor can check a line in seconds instead of guessing whether the AI got it right
- Notes form in real time, during the visit, rather than after — the doctor can review and sign before the patient has even left the room
- Deep, specific integration with Epic, the electronic health record system most large U.S. hospitals already run, including pulling orders and prior authorization requests straight out of the same conversation
- Two years running, independent healthcare IT researchers at KLAS have ranked Abridge the top ambient AI scribe on the market — that's not a company claim, it's an outside ranking
- Deployed at some of the most recognizable health systems in the country, including Mayo Clinic, Johns Hopkins, and Kaiser Permanente, which tells you real, cautious institutions have put it through serious vetting before buying in
Cons
- There's no self-serve plan and no published price. If you're an individual doctor or a small practice, you can't just sign up — you need your health system to run a full procurement process, and that alone rules Abridge out for a lot of smaller providers
- Reported pricing runs roughly $2,500 to $7,200 or more per provider a year, and multi-year contracts leave little room to adjust if your needs change or the price goes up
- The most careful independent study of this product found real-world time savings under a minute per note — a genuine improvement, but smaller than some of the more dramatic satisfaction numbers might lead you to expect going in
- The company has raised close to a billion dollars at a multi-billion dollar valuation, which industry analysts have flagged as a real pressure point — that level of investor expectation often pushes prices up or moves features behind higher tiers over time
- It's narrower than some competitors. There's no built-in AI receptionist, fax handling, or payment collection — if you want documentation and everything else bundled into one tool, you'll be looking at a different product alongside it
At a glance
Best for
Features
Industries
Our review of Abridge
What it actually is
A doctor opens the Abridge app on a phone or tablet, gets the patient’s consent, and hits record during the visit. The app listens, tells apart who’s speaking, and builds a structured note as the conversation happens—the history of the visit history, exam findings, diagnosis, and plan —sorted into the sections a medical record actually needs. Every piece of that note links back to the exact moment in the recording that generated it, so the doctor can double-check anything before signing off instead of trusting it blindly.
Beyond the note itself, Abridge has been pushing further into the parts of a visit that turn into paperwork and money — pulling orders directly out of the conversation inside Epic, and working with insurers on faster prior authorization. It’s also started building a clinical foundation model with Nvidia, aimed specifically at medical conversations rather than general text. None of this is sold to individual users. Every deployment goes through a health system’s own IT and purchasing process, and pricing isn’t published — you get a quote.
Where it’s genuinely good
The linked-evidence design is the feature that matters most in practice, and it’s easy to miss why. A note that just appears, fully written, asks a doctor to trust it. A note where every line points back to a timestamped clip of the actual conversation asks the doctor to check it — and checking takes seconds instead of minutes. That difference is a big part of why the research keeps finding that doctors trust and actually use this tool rather than quietly going back to typing everything themselves.
The clinical credibility behind it is real too. Two peer-reviewed studies have measured a genuine drop in the mental burden doctors carry using a standard tool built for exactly that purpose, and a randomized study at a major academic medical center found doctors were five times more likely to finish a note before their next patient walked in, instead of doing it at home that night. That’s the kind of result a health system’s leadership cares about when burnout drives doctors to cut hours or leave the profession.
Where it falls short
The access problem is the first thing worth knowing. If you’re not part of a health system big enough to run its own procurement process, you can’t try this product at all — there’s no free trial, no monthly plan, nothing you can sign up for on your own. That alone puts it out of reach for many doctors in smaller and independent practices, whatever the product itself is worth.
The time-savings question deserves an honest look too. Several studies Abridge itself highlights focus on burnout, satisfaction, and attention during the visit — all real and worth caring about. But the most careful, independently run study of this specific product measured the actual clock time saved per note, and it came out under a minute. That’s nothing across a full day of patients, but it’s a much smaller number than the surrounding marketing conversation tends to suggest, and it’s worth going in with the accurate expectation rather than the more dramatic one.
Which plan to actually get
There’s only one path in: an enterprise agreement, negotiated directly with Abridge’s sales team, priced per provider and typically locked into a multi-year contract. If your organization is already running Epic and has the scale to justify that kind of commitment, the integration depth makes the case for itself. If you’re a smaller practice evaluating whether this is even worth pursuing, the honest first step is asking Abridge directly for a quote and a pilot period before committing to anything longer, since there’s no lighter-weight way to test the waters first.
Ease of use
For the doctor in the room, this is about as simple as it gets — open the app, get consent, hit record, and review a finished note afterward instead of typing one from scratch. The friction is entirely on the front end, before a single doctor ever uses it: getting your organization through procurement, integration with your existing EHR, and training staff on the new workflow all take real time and coordination that a smaller practice usually can’t manage on its own.
Who it’s actually for
Large health systems already running Epic, with the scale and IT resources to manage a full enterprise rollout and the budget to back a multi-year contract. It’s a strong fit specifically for organizations where physician burnout and documentation burden are a real, measured problem leadership is trying to solve, since that’s exactly where the peer-reviewed evidence is strongest. It’s not a fit for an individual doctor or a small independent practice looking for something they can just sign up for and start using this week — that group will need to look at a different, self-serve product instead.
Company scale and deployment
- Funding: About $800 million raised; $5.3 billion valuation as of its 2025 Series E, with a further raise in April 2026
- Deployment: 250+ U.S. health systems, including Mayo Clinic, Duke Health, Johns Hopkins, and Kaiser Permanente
Information & verification
We use official product, pricing and documentation sources where possible and date-stamp profiles so changing AI products can be rechecked.
Editorially assessed using Indexura’s published methodology.
Features and pricing can change. Check the official source before purchase.
Similar tools to Abridge
Explore products that overlap in category, use case, capabilities or industry fit.
Grok
Grok is xAI's flagship assistant, built by Elon Musk's company and now running as part of a business empire that also includes X and,…
View profile →
ElevenLabs
ElevenLabs is the company most people mean when they say an AI voice sounds real. What started as a text-to-speech tool in 2022 has…
View profile →Mistral AI
Mistral AI is the Paris-based lab that built itself into Europe's answer to OpenAI and Anthropic — open model weights, a European privacy pitch,…
View profile →